Zynex to develop central blood volume monitoring device

Zynex, Inc. (OTCBB: ZYXI), a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that its newly formed wholly-owned subsidiary, Zynex Monitoring Solutions Inc., is developing a device for monitoring of central blood volume for use in operating rooms, detecting blood loss during surgery and detecting internal bleeding in the recovery room. A provisional patent has been filed for this unique application, which could serve a currently untapped market of safer surgeries and safer monitoring of patients during recovery.

Thomas Sandgaard, Zynex's CEO, comments: "We already have data confirming the conceptual design and our on-going engineering and prototyping efforts are showing very promising progress. At this early stage, we are also finding that this technology can be used for other applications in cardiac monitoring, and we will continue to explore those options, as stand-alone devices or combined with the blood volume monitoring. We will continue to increase the staff and resources in Monitoring Solutions in order to launch an exciting line of products as soon as possible. We hope to add other complementary technologies, while we initially share some resources with the existing business of electrotherapy products in Zynex Medical, such as clinical research, quality assurance, accounting, purchasing, etc. We are very excited that our initial development effort is showing such positive progress and look forward to further developing a line of products and a strong organization for Monitoring Solutions."